IBM, A*Star co-develop anti-microbial hydrogel
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 24 Jan, 2013
Singapore: Researchers from A*Star's Institute of Bioengineering and Nanotechnology (IBN) and IBM have unveiled first-e...Read more
Pfizer launches targeted therapy for lung cancer in Singapore
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 04 Aug, 2015
Singapore: Pfizer has launched Xalkori, a targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), in Singa...Read more
HSA nod for Aslan rheumatoid arthritis drug
Drug Discovery | Regulatory | By BioSpectrum Bureau | 0 Comment | 23 Apr, 2013
Singapore: Aslan Pharmaceuticals received approval by the Singapore Health Sciences Authority (HSA) for its Clinical Tri...Read more
Celsion launches cancer drug trial in China
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 08 Mar, 2016
Singapore: Celsion Corporation, a fully-integrated oncology company focused on the development of a portfolio of innovat...Read more
China SFDA passes Sihuan Pharma's Roxatidine
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 28 May, 2012
Singapore: Sihuan Pharmaceutical Holdings' roxatidine acetate hydrochloride for injection (Roxatidine), which is the com...Read more
Takeda, DND to accelerate drug discovery for parasite infection
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 29 Jul, 2015
Singapore: Geneva based Drugs for Neglected Diseases and Japan's Takeda have collaborated for a Lead Optimization Progra...Read more
Abbott marks success with naturally dissolving stent in Japan
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Sep, 2015
Global life sciences company Abbott has announced that the company has observed positive clinical results from ABSORB Ja...Read more
BI shows afatinib to be effective in advanced squamous cell carcinoma of lung
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jun, 2015
Singapore: Boehringer Ingelheim has achieved positive results from the trial of afatinib in comparison to erlotinib in p...Read more
Novartis partners with Mereo BioPharma to enhance novel drug portfolio
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 31 Jul, 2015
Singapore: Novartis has partnered with UK based Mereo BioPharma to develop compounds including BPS-804, to improve bone ...Read more
Jubilant Biosys collaborates with Sanofi to develop metabolic disorders therapy
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 11 Jan, 2016
Singapore: India based Jubilant Biosys, subsidiary of Jubilant Life Sciences, and Germany based Sanofi Deutschland have ...Read more
Amgen terninates phase III cancer trial
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 09 Aug, 2012
Singapore: Amgen decided to stop the ganitumab (AMG 479) phase III GAMMA (gemcitabine and AMG 479 in metastatic adenocar...Read more
Minerva derives positive outcome of Insomnia drug study in Japanese patients
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 02 Feb, 2016
NASDAQ-listed Minerva Neurosciences Inc, a clinical-stage biopharmaceutical company focused on the development of therap...Read more
Singapore cancer genome scientists win President's Science Award
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 17 Sep, 2015
Singapore: A team comprising Professor Patrick Tan from Duke-NUS Graduate Medical School (Duke-NUS) and A*STAR's Genome ...Read more
Positive results for Otsuka's MDR-TB treatment
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 07 Jun, 2012
Singapore: Clinical trial results on the safety and efficacy of delamanid, Otsuka Pharmaceutical's investigational compo...Read more
Boehringer, Lilly complete type 2 diabetes study
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 12 Nov, 2012
Singapore: Recruitment of patients for CAROLINA (cardiovascular outcome study of Linagliptin versus Glimepiride in patie...Read more
Linagliptin efficacy further established in specific patient populations
Drug Discovery | News | By Nandita Singh | 0 Comment | 12 Nov, 2013
Seoul: Boehringer Ingelheim and Eli Lilly & Company have announced new data that reinforces the efficacy and tolerab...Read more
CSL Behring seeks Japan PMDA approval for Hemophilia drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 22 Dec, 2015
Global biotherapeutics company CSL Behring has submitted its new drug application (NDA) to Japan's Pharmaceuticals and M...Read more
Boehringer Ingelheim, Hanmi to co-develop lung cancer drug
Drug Discovery | News | By BioSpectrum Bureau | 0 Comment | 30 Jul, 2015
Singapore: Boehringer Ingelheim and Korea's Hanmi Pharmaceutical have collaborated for the development and global commer...Read more